市场调查报告书

再生医疗的全球市场:各治疗方法 (细胞疗法,遗传基因疗法)、产品 (自我细胞/同种异体细胞/无细胞)、用途、地区的预测

Regenerative Medicine Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品编码 422454
出版日期 内容资讯 英文 103 Pages
商品交期: 2-3个工作天内
价格
再生医疗的全球市场:各治疗方法 (细胞疗法,遗传基因疗法)、产品 (自我细胞/同种异体细胞/无细胞)、用途、地区的预测 Regenerative Medicine Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日内容资讯: 英文 103 Pages
简介

本报告提供全球再生医疗的相关市场相关分析,关于产品概要和整体市场结构,主要的推动及阻碍市场要素,各治疗法、各产品、各用途、各地区的市场趋势预测 (今后7年份),市场竞争概况,近来的资本交易、策略发展的动向,主要企业简介等调查评估。

第1章 再生医疗:市场概况

第2章 摘要整理

第3章 市场环境

  • 市场占有率分析
  • 比较分析
  • 产品的互相比较
  • 终端用户简介
  • 前五名公司的财务分析

第4章 再生医疗市场影响要素

  • 推动市场要素
  • 阻碍市场要素
  • 市场机会
  • 课题
  • 波特的五力分析

第5章 再生医疗市场:策略分析

  • 价值链分析
  • 价格趋势分析
  • 市场机会分析
  • 产品/市场生命周期分析
  • 供应商、经销商

第6章 再生医疗市场:各治疗法

  • 细胞疗法
  • 遗传基因疗法
  • 组织工程
  • 免疫疗法

第7章 再生医疗市场:各产品

  • 自我细胞产品
  • 同种异体细胞产品
  • 无细胞产品

第8章 再生医疗市场:各用途

  • 整形外科、肌肉骨骼系统脊椎
  • 皮肤
  • 心血管
  • 中枢神经系统 (CNS)
  • 肿瘤
  • 糖尿病
  • 其他

第9章 再生医疗市场:各地区

  • 欧洲 (德国、法国、义大利、西班牙、俄罗斯、英国等)
  • 亚太地区 (中国、日本、印度、韩国等)
  • 北美 (美国、加拿大、墨西哥)
  • 其他的国家 (RoW) (巴西等)

第10章 再生医疗市场:市场变化的方向性

  • 产业扩张
  • 技术进步
  • 企业合并、收购 (M&A),合资企业
  • 供给契约

第11章 企业简介

第12章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: HCR 0366

As per the Organ Procurement and Transplantation Network, 36,527 organ transplants were accomplished in the United States in 2018[1]. Regenerative medicines plays a vital role in transplants as it refers to an interdisciplinary field and is a branch of translational research that applies engineering and life science principles to promote regeneration, and can potentially restore diseased and injured tissues as well as whole organs. Apart from organ regeneration, regenerative medicines are effective in cell therapy, gene therapy, and tissue engineering, and are applicable in cardiology, oncology, dermatology, and ophthalmology. Owing to higher prevalence of chronic diseases, genetic diseases, and aging population, causing a higher requirement for organs and biomaterials for tissue regeneration, the regenerative medicine market has escalated to be valued in between $26 billion-$27 billion as of 2018. The analyst of this business intelligence report has tracked this developing marketplace to be progressing economically at a CAGR of 22%-24% during the forecast period 2019-2025.

Regenerative Medicine Market Outlook:

According to Global Burden of Disease, a study by WHO, musculoskeletal conditions are the second highest contributor to global disability. And, Institute for Health Metrics and Evaluation (IHME) has revealed that the total burden of disability increased by 52% between 1990 and 2017.

Gene therapy and tissue engineering in orthopedic surgery endures to assist as the foundation for innovative treatments of innumerable musculoskeletal disorders. Regenerative medicine market is all established to capitalize on the global musculoskeletal disorder rate as it assists in tissue engineering and therapy. Due to such occurrences, orthopedic & musculoskeletal cases dominate the application segment and is flourishing with an application CAGR of 21%-23% going through 2025.

After an acute analysis of the regional aspects of regenerative medicine market, North America has been located as the leading region encapsulating under its terrain around 30%-32% of the global regenerative medicine market demand. The sheer affluence of this region can be attributed to several facts. The United States with its existing modern and cutting-edge healthcare infrastructure is compatible for intricate medical outputs such as stem cell and oncology research augmenting regenerative market. Accelerating frequency of ailments, for instance cancer and diabetes, in the United Sates is positively affecting the market. National Cancer Institute estimated the nationwide expenses for cancer care in the United States in 2017 were $147.3 billion[2]. Similarly 23.1 million folks in the United States are diagnosed with diabetes at a cost of more than $245 billion per year[3]. Awareness among population regarding the available stem cell procedures and therapies effectively curing cancer and diabetes is increasing, which consequence in increasing the demand for the regenerative medicine market.

Regenerative Medicine Market Growth Drivers and Trends:

One of the major drivers of regenerative medicine market is the growing research and developments activities and innovations and funding in biomaterials, nanotechnology, drug delivery, and cell therapies.

The 21st Century Cures Act, approved in December 2016, created room for establishment of Regenerative Medicine Innovation Project (RMIP). NIH (National Institute of Health) is leading the RMIP in coordination with FDA. The 21st Century Cures Act approved $30 million in federal awards over four years (2017-2020) for the RMIP, thus accelerating the arena by aiding clinical research on mature stem cells while endorsing the uppermost morals for scientific research and patient safety[4].

Socio-economic context is restricting folks from developing economies to afford organ transplantation. Inadequate stock of organs is instigating serious crime of organ trafficking common in Pakistan, India, and China. This circumstantial setting requires to be disrupted with abrupt response and demands for discovery an alternative source of organ transplantation such as regenerative medicine.

Regenerative Medicine Market Challenges:

Emerging economies with mounting instances of chronic diseases, genetic diseases, and aging population, where there is a higher demand for organs and biomaterials for tissue regeneration have low awareness of developments in regenerative medicine due to low healthcare expenditure.

But however, research and developments with adequate influx of investments and funding are progressing towards economical commercialization of such intricate medical procedures.

Regenerative Medicine Market Players Perspective:

Vertex Pharmaceuticals Incorporated, Medtronic Plc, Allegan Plc, Smith & Nephew Plc, Nuvasive, Inc, Cytori Therapeutics, Inc, Vericel Corporation, BlueRock Therapeutics, Octane Biotech Inc, and Theracell Advanced Biotechnology Ltd are some of the key players functional and effective in the regenerative medicine market.

Vertex Pharmaceuticals Incorporated, revealed on February 12, 2018 that their third medicine SYMDEKO™ got approved by FDA for cystic fibrosis (CF), a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys, and intestine. Such developments curate the future revenue for regenerative medicine market.

Regenerative Medicine Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the regenerative medicine market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various researches in regenerative medicine market, and their specific applications in different types of ailments.

Regenerative Medicine Market Report: Industry Coverage

By Products: Analyzers, Reagents

End Users: Hospitals, Clinical Laboratories, Academics

By Applications: Oncology, Microbiology, Others

The regenerative medicine market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

Key Questions Addressed in the Regenerative Medicine Market Report

1. Is the market for regenerative medicine growing? How long will it continue to grow and at what rate?

2. Which type of diagnostics presents the major growth opportunities?

3. Is there a possibility for change in the market structure over time?

4. Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands?

5. Do the key vendors look for partnerships to expand their businesses with respect to geography or product?

6. What are the short-term, long-term, and medium-term growth drivers for the market?

7. What are the short-term, medium-term, and long-term challenges for the market?

8. What are the short-term, medium-term, and long-term opportunities for the market

9. Who are the top players/companies of the market?

10. What are the recent innovations in the market?

11. How many patents have been filed by the leading players?

12. What are the types of patents filed by the leading players?

13. What is our Vision 2030 for Regenerative Medicine Market?

A few focus points of this Research are given below:

Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies

Provide an overview of the product portfolio, including product planning, development, and positioning

Discuss the role of technology companies in partnerships

Explore the regional sales activities

Analyze the market size and giving the forecast for current and future regenerative medicine during the forecast 2018-2023

Analyze the competitive factors, competitors' market shares, product capabilities, and supply chain structures

1. Regenerative Medicine Market - Market Overview

  • 1.1. Definitions and Scope

2. Regenerative Medicine Market - Executive Summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends Segmented by Geography

3. Regenerative Medicine Market - Market Landscape

  • 3.1. Comparative Analysis
    • 3.1.1. Product Benchmarking - Top 10 Companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value Split by Key Companies
    • 3.1.4. Pricing Analysis

4. Regenerative Medicine Market - Startup Companies Scenario

  • 4.1. Key Startup Company Analysis by
    • 4.1.1. Investment
    • 4.1.2. Revenue
    • 4.1.3. Venture Capital and Funding Scenario

5. Regenerative Medicine Market - Market Forces

  • 5.1. Drivers
  • 5.2. Constraints & Challenges
  • 5.3. Porter's Five Force Model
    • 5.3.1. Bargaining Power of Suppliers
    • 5.3.2. Bargaining Power of Customers
    • 5.3.3. Threat of New Entrants
    • 5.3.4. Rivalry Among Existing Players
    • 5.3.5. Threat of Substitutes

6. Regenerative Medicine Market - Strategic Analysis

  • 6.1. Value Chain Analysis
  • 6.2. Opportunities Analysis
  • 6.3. Market Life Cycle

7. Regenerative Medicine Market - By Therapy (Market Size - $Million/$Billion)

  • 7.1. Market Size and Market Share Analysis
  • 7.2. Therapy Segment Analysis
    • 7.2.1. Cell Therapy
    • 7.2.2. Gene Therapy
    • 7.2.3. Tissue Engineering
    • 7.2.4. Others

8. Regenerative Medicine Market - By Product (Market Size - $Million/$Billion)

  • 8.1. Market Size and Market Share Analysis
  • 8.2. Product Segment Analysis
    • 8.2.1. Cell-Based Products
      • 8.2.1.1. Allogeneic Products
      • 8.2.1.2. Autologous Products
    • 8.2.2. Acellular Products

9. Regenerative Medicine Market - By Material (Market Size - $Million/$Billion)

  • 9.1. Market Size and Market Share Analysis
  • 9.2. Material Segment Analysis
    • 9.2.1. Synthetic Material
      • 9.2.1.1. Biodegradable Synthetic Polymers
      • 9.2.1.2. Scaffold
      • 9.2.1.3. Artificial Vascular Graft Materials
      • 9.2.1.4. Hydrogel Materials
    • 9.2.2. Biologically Derived Material
      • 9.2.2.1. Collagen
      • 9.2.2.2. Xenogeneic Material
    • 9.2.3. Genetically Engineered Material
      • 9.2.3.1. Genetically Manipulated Cells
      • 9.2.3.2. 3D Polymer Technology
      • 9.2.3.3. Transgenic
      • 9.2.3.4. Fibroblast
      • 9.2.3.5. Neural Stem Cells
      • 9.2.3.6. Gene-activated Matrices
    • 9.2.4. Pharmaceutical
      • 9.2.4.1. Small Molecules
      • 9.2.4.2. Biologics

10. Regenerative Medicine Market - By Application (Market Size - $Million/$Billion)

  • 10.1. Market Size and Market Share Analysis
  • 10.2. Application Segment Analysis
    • 10.2.1. Orthopedic & Musculoskeletal
    • 10.2.2. Cardiovascular
    • 10.2.3. Oncology
    • 10.2.4. Dermatology
    • 10.2.5. Neurology
    • 10.2.6. Ophthalmology
    • 10.2.7. Hematology & Immunology
    • 10.2.8. Diabetes
    • 10.2.9. Esophagus
    • 10.2.10. Dental
    • 10.2.11. Others

11. Regenerative Medicine Market - By Geography (Market Size - $Million/$Billion)

  • 11.1. Regenerative Medicine Market - North America Segment Research
  • 11.2. North America Market Research (Market Size - $Million/$Billion)
    • 11.2.1. Segment Size and Market Size Analysis
    • 11.2.2. Revenue and Trends
    • 11.2.3. Therapy Analysis
    • 11.2.4. Product Industry Analysis
    • 11.2.5. Material Industry Analysis
    • 11.2.6. Application Analysis
    • 11.2.7. North America Segment Analysis
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Regenerative Medicine Market - South America Segment Research
  • 11.4. South America Market Research (Market Size - $Million/$Billion)
    • 11.4.1. Segment Size and Market Size Analysis
    • 11.4.2. Revenue and Trends
    • 11.4.3. Therapy Analysis
    • 11.4.4. Product Industry Analysis
    • 11.4.5. Material Industry Analysis
    • 11.4.6. Application Analysis
    • 11.4.7. South America Segment Analysis
      • 11.4.7.1. Brazil
      • 11.4.7.2. Chile
      • 11.4.7.3. Argentina
      • 11.4.7.4. Rest of South America
  • 11.5. Regenerative Medicine Market - Europe Segment Research
  • 11.6. Europe Market Research (Market Size - $Million/$Billion)
    • 11.6.1. Segment Size and Market Size Analysis
    • 11.6.2. Revenue and Trends
    • 11.6.3. Therapy Analysis
    • 11.6.4. Product Industry Analysis
    • 11.6.5. Material Industry Analysis
    • 11.6.6. Application Analysis
    • 11.6.7. Europe Segment Analysis
      • 11.6.7.1. U.K.
      • 11.6.7.2. Germany
      • 11.6.7.3. Italy
      • 11.6.7.4. France
      • 11.6.7.5. Russia
      • 11.6.7.6. Spain
      • 11.6.7.7. Rest of Europe
  • 11.7. Regenerative Medicine Market - APAC Segment Research
  • 11.8. Asia Pacific Market Research (Market Size - $Million/$Billion)
    • 11.8.1. Segment Size and Market Size Analysis
    • 11.8.2. Revenue and Trends
    • 11.8.3. Therapy Analysis
    • 11.8.4. Product Industry Analysis
    • 11.8.5. Material Industry Analysis
    • 11.8.6. Application Analysis
    • 11.8.7. APAC Segment Analysis
      • 11.8.7.1. China
      • 11.8.7.2. Australia
      • 11.8.7.3. Japan
      • 11.8.7.4. South Korea
      • 11.8.7.5. India
      • 11.8.7.6. Rest of APAC
  • 11.9. Regenerative Medicine Market - Middle East Segment and Africa Segment Research
  • 11.10. Middle East and Africa Market Research (Market Size - $Million/$Billion)
    • 11.10.1. Segment type Size and Market Size Analysis
    • 11.10.2. Revenue and Trends
    • 11.10.3. Therapy Analysis
    • 11.10.4. Product Industry Analysis
    • 11.10.5. Material Industry Analysis
    • 11.10.6. Application Analysis
    • 11.10.7. Middle East & Africa Segment Analysis
      • 11.10.7.1. Middle East
      • 11.10.7.2. Africa

12. Regenerative Medicine Market - Market Entropy

13. Regenerative Medicine Market Company Analysis

  • 13.1. Market Share, Company Revenue, Products, M&A, Developments
  • 13.2. Vertex Pharmaceuticals Inc. (U.S.)
  • 13.3. Medtronic Plc (Ireland)
  • 13.4. NuVasive, Inc. (U.S.)
  • 13.5. Integra LifeSciences Holdings Corporation (U.S.)
  • 13.6. Smith & Nephew Plc (U.K.)
  • 13.7. Mesoblast Ltd. (Australia)
  • 13.8. Vericel Corporation (U.S.)
  • 13.9. Athersys, Inc. (U.S.)
  • 13.10. Exactech, Inc. (U.S.)
  • 13.11. Company 10
  • 13.12. Company 11
  • 13.13. Company 12 and more

"*Financials of private companies will be provided on a best-efforts basis"

14. Regenerative Medicine Market - Appendix

  • 14.1. Abbreviations
  • 14.2. Sources

15. Regenerative Medicine Market - Methodology

  • 15.1. Research Methodology
    • 15.1.1. Company Expert Interviews
    • 15.1.2. Industry Databases
    • 15.1.3. Associations
    • 15.1.4. Company News
    • 15.1.5. Company Annual Reports
    • 15.1.6. Application Trends
    • 15.1.7. New Products and Product Database
    • 15.1.8. Company Transcripts
    • 15.1.9. R&D Trends
    • 15.1.10. Key Opinion Leaders Interviews
    • 15.1.11. Supply and Demand Trends